These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24045556)

  • 1. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc Sulfate, a Recently Introduced Urinary Adulterant Can Invalidate Urine Cotinine Test Using Immunoassay but Has Less Effect on Liquid Chromatography Combined With Tandem Mass Spectrometry-Based Test.
    Dixon RB; Dasgupta A
    Ther Drug Monit; 2015 Oct; 37(5):681-4. PubMed ID: 25627403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
    Reisfield GM; Goldberger BA; Bertholf RL
    Bioanalysis; 2009 Aug; 1(5):937-52. PubMed ID: 21083064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adulteration of urine by "Urine Luck".
    Wu AH; Bristol B; Sexton K; Cassella-McLane G; Holtman V; Hill DW
    Clin Chem; 1999 Jul; 45(7):1051-7. PubMed ID: 10388482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug-testing tampering approaches: Turkish probationers.
    Aydoğdu M; Akgür SA
    Med Sci Law; 2021 Jan; 61(1):6-13. PubMed ID: 32924786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing.
    Venkatratnam A; Lents NH
    J Anal Toxicol; 2011 Jul; 35(6):333-40. PubMed ID: 21740689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory and clinical evaluation of on-site urine drug testing.
    Beck O; Carlsson S; Tusic M; Olsson R; Franzen L; Hulten P
    Scand J Clin Lab Invest; 2014 Nov; 74(8):681-6. PubMed ID: 25046332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.